HHS lays groundwork for new FDA rule on releasing CRLs

July 8, 2026 12:04 PM EDT PharmaFDA+ HHS lays ground­work for new FDA rule on re­leas­ing the CRLs Zachary Brennan Senior Editor The Trump ad­min­is­tra­tion is push­ing the FDA to ce­ment the de­tails be­hind its proac­tive pub­lic re­lease of re­jec­tion let­ters sent to phar­ma com­pa­nies. The rule­mak­ing … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER